Assessment of Betulinic Acid Cytotoxicity and Mitochondrial Metabolism Impairment in a Human Melanoma Cell Line. 2021

Dorina Coricovac, and Cristina Adriana Dehelean, and Iulia Pinzaru, and Alexandra Mioc, and Oana-Maria Aburel, and Ioana Macasoi, and George Andrei Draghici, and Crina Petean, and Codruta Soica, and Madalina Boruga, and Brigitha Vlaicu, and Mirela Danina Muntean
Faculty of Pharmacy, "Victor Babeș" University of Medicine and Pharmacy Timișoara, Eftimie Murgu Square No. 2, RO-300041 Timișoara, Romania.

Melanoma represents one of the most aggressive and drug resistant skin cancers with poor prognosis in its advanced stages. Despite the increasing number of targeted therapies, novel approaches are needed to counteract both therapeutic resistance and the side effects of classic therapy. Betulinic acid (BA) is a bioactive phytocompound that has been reported to induce apoptosis in several types of cancers including melanomas; however, its effects on mitochondrial bioenergetics are less investigated. The present study performed in A375 human melanoma cells was aimed to characterize the effects of BA on mitochondrial bioenergetics and cellular behavior. BA demonstrated a dose-dependent inhibitory effect in both mitochondrial respiration and glycolysis in A375 melanoma cells and at sub-toxic concentrations (10 μM) induced mitochondrial dysfunction by eliciting a decrease in the mitochondrial membrane potential and changes in mitochondria morphology and localization. In addition, BA triggered a dose-dependent cytotoxic effect characterized by apoptotic features: morphological alterations (nuclear fragmentation, apoptotic bodies) and the upregulation of pro-apoptotic markers mRNA expression (Bax, Bad and Bak). BA represents a viable therapeutic option via a complex modulatory effect on mitochondrial metabolism that might be useful in advanced melanoma or as reliable strategy to counteract resistance to standard therapy.

UI MeSH Term Description Entries
D008544 Melanocytes Mammalian pigment cells that produce MELANINS, pigments found mainly in the EPIDERMIS, but also in the eyes and the hair, by a process called melanogenesis. Coloration can be altered by the number of melanocytes or the amount of pigment produced and stored in the organelles called MELANOSOMES. The large non-mammalian melanin-containing cells are called MELANOPHORES. Melanocyte
D008928 Mitochondria Semiautonomous, self-reproducing organelles that occur in the cytoplasm of all cells of most, but not all, eukaryotes. Each mitochondrion is surrounded by a double limiting membrane. The inner membrane is highly invaginated, and its projections are called cristae. Mitochondria are the sites of the reactions of oxidative phosphorylation, which result in the formation of ATP. They contain distinctive RIBOSOMES, transfer RNAs (RNA, TRANSFER); AMINO ACYL T RNA SYNTHETASES; and elongation and termination factors. Mitochondria depend upon genes within the nucleus of the cells in which they reside for many essential messenger RNAs (RNA, MESSENGER). Mitochondria are believed to have arisen from aerobic bacteria that established a symbiotic relationship with primitive protoeukaryotes. (King & Stansfield, A Dictionary of Genetics, 4th ed) Mitochondrial Contraction,Mitochondrion,Contraction, Mitochondrial,Contractions, Mitochondrial,Mitochondrial Contractions
D010085 Oxidative Phosphorylation Electron transfer through the cytochrome system liberating free energy which is transformed into high-energy phosphate bonds. Phosphorylation, Oxidative,Oxidative Phosphorylations,Phosphorylations, Oxidative
D005786 Gene Expression Regulation Any of the processes by which nuclear, cytoplasmic, or intercellular factors influence the differential control (induction or repression) of gene action at the level of transcription or translation. Gene Action Regulation,Regulation of Gene Expression,Expression Regulation, Gene,Regulation, Gene Action,Regulation, Gene Expression
D006019 Glycolysis A metabolic process that converts GLUCOSE into two molecules of PYRUVIC ACID through a series of enzymatic reactions. Energy generated by this process is conserved in two molecules of ATP. Glycolysis is the universal catabolic pathway for glucose, free glucose, or glucose derived from complex CARBOHYDRATES, such as GLYCOGEN and STARCH. Embden-Meyerhof Pathway,Embden-Meyerhof-Parnas Pathway,Embden Meyerhof Parnas Pathway,Embden Meyerhof Pathway,Embden-Meyerhof Pathways,Pathway, Embden-Meyerhof,Pathway, Embden-Meyerhof-Parnas,Pathways, Embden-Meyerhof
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000094062 Betulinic Acid A lupane-type triterpene derivative of betulin which was originally isolated from BETULA or birch tree. It has anti-inflammatory, anti-HIV and antineoplastic activities. 3-Epi-betulinic Acid,3-Hydroxy-lup-20(29)-en-28-oic Acid,3-Hydroxylup-20(29)-en-28-oic Acid,Betulic Acid,3 Epi betulinic Acid
D000972 Antineoplastic Agents, Phytogenic Agents obtained from higher plants that have demonstrable cytostatic or antineoplastic activity. Antineoplastics, Botanical,Antineoplastics, Phytogenic,Agents, Phytogenic Antineoplastic,Botanical Antineoplastics,Phytogenic Antineoplastic Agents,Phytogenic Antineoplastics
D015398 Signal Transduction The intracellular transfer of information (biological activation/inhibition) through a signal pathway. In each signal transduction system, an activation/inhibition signal from a biologically active molecule (hormone, neurotransmitter) is mediated via the coupling of a receptor/enzyme to a second messenger system or to an ion channel. Signal transduction plays an important role in activating cellular functions, cell differentiation, and cell proliferation. Examples of signal transduction systems are the GAMMA-AMINOBUTYRIC ACID-postsynaptic receptor-calcium ion channel system, the receptor-mediated T-cell activation pathway, and the receptor-mediated activation of phospholipases. Those coupled to membrane depolarization or intracellular release of calcium include the receptor-mediated activation of cytotoxic functions in granulocytes and the synaptic potentiation of protein kinase activation. Some signal transduction pathways may be part of larger signal transduction pathways; for example, protein kinase activation is part of the platelet activation signal pathway. Cell Signaling,Receptor-Mediated Signal Transduction,Signal Pathways,Receptor Mediated Signal Transduction,Signal Transduction Pathways,Signal Transduction Systems,Pathway, Signal,Pathway, Signal Transduction,Pathways, Signal,Pathways, Signal Transduction,Receptor-Mediated Signal Transductions,Signal Pathway,Signal Transduction Pathway,Signal Transduction System,Signal Transduction, Receptor-Mediated,Signal Transductions,Signal Transductions, Receptor-Mediated,System, Signal Transduction,Systems, Signal Transduction,Transduction, Signal,Transductions, Signal
D017209 Apoptosis A regulated cell death mechanism characterized by distinctive morphologic changes in the nucleus and cytoplasm, including the endonucleolytic cleavage of genomic DNA, at regularly spaced, internucleosomal sites, i.e., DNA FRAGMENTATION. It is genetically programmed and serves as a balance to mitosis in regulating the size of animal tissues and in mediating pathologic processes associated with tumor growth. Apoptosis, Extrinsic Pathway,Apoptosis, Intrinsic Pathway,Caspase-Dependent Apoptosis,Classic Apoptosis,Classical Apoptosis,Programmed Cell Death,Programmed Cell Death, Type I,Apoptoses, Extrinsic Pathway,Apoptoses, Intrinsic Pathway,Apoptosis, Caspase-Dependent,Apoptosis, Classic,Apoptosis, Classical,Caspase Dependent Apoptosis,Cell Death, Programmed,Classic Apoptoses,Extrinsic Pathway Apoptoses,Extrinsic Pathway Apoptosis,Intrinsic Pathway Apoptoses,Intrinsic Pathway Apoptosis

Related Publications

Dorina Coricovac, and Cristina Adriana Dehelean, and Iulia Pinzaru, and Alexandra Mioc, and Oana-Maria Aburel, and Ioana Macasoi, and George Andrei Draghici, and Crina Petean, and Codruta Soica, and Madalina Boruga, and Brigitha Vlaicu, and Mirela Danina Muntean
September 2004, European journal of pharmacology,
Dorina Coricovac, and Cristina Adriana Dehelean, and Iulia Pinzaru, and Alexandra Mioc, and Oana-Maria Aburel, and Ioana Macasoi, and George Andrei Draghici, and Crina Petean, and Codruta Soica, and Madalina Boruga, and Brigitha Vlaicu, and Mirela Danina Muntean
January 1982, Cancer treatment reports,
Dorina Coricovac, and Cristina Adriana Dehelean, and Iulia Pinzaru, and Alexandra Mioc, and Oana-Maria Aburel, and Ioana Macasoi, and George Andrei Draghici, and Crina Petean, and Codruta Soica, and Madalina Boruga, and Brigitha Vlaicu, and Mirela Danina Muntean
September 2009, Drug discovery today,
Dorina Coricovac, and Cristina Adriana Dehelean, and Iulia Pinzaru, and Alexandra Mioc, and Oana-Maria Aburel, and Ioana Macasoi, and George Andrei Draghici, and Crina Petean, and Codruta Soica, and Madalina Boruga, and Brigitha Vlaicu, and Mirela Danina Muntean
July 1998, Bioorganic & medicinal chemistry letters,
Dorina Coricovac, and Cristina Adriana Dehelean, and Iulia Pinzaru, and Alexandra Mioc, and Oana-Maria Aburel, and Ioana Macasoi, and George Andrei Draghici, and Crina Petean, and Codruta Soica, and Madalina Boruga, and Brigitha Vlaicu, and Mirela Danina Muntean
January 1989, Cancer letters,
Dorina Coricovac, and Cristina Adriana Dehelean, and Iulia Pinzaru, and Alexandra Mioc, and Oana-Maria Aburel, and Ioana Macasoi, and George Andrei Draghici, and Crina Petean, and Codruta Soica, and Madalina Boruga, and Brigitha Vlaicu, and Mirela Danina Muntean
May 2021, Zhongguo ying yong sheng li xue za zhi = Zhongguo yingyong shenglixue zazhi = Chinese journal of applied physiology,
Dorina Coricovac, and Cristina Adriana Dehelean, and Iulia Pinzaru, and Alexandra Mioc, and Oana-Maria Aburel, and Ioana Macasoi, and George Andrei Draghici, and Crina Petean, and Codruta Soica, and Madalina Boruga, and Brigitha Vlaicu, and Mirela Danina Muntean
August 1975, Journal of immunology (Baltimore, Md. : 1950),
Dorina Coricovac, and Cristina Adriana Dehelean, and Iulia Pinzaru, and Alexandra Mioc, and Oana-Maria Aburel, and Ioana Macasoi, and George Andrei Draghici, and Crina Petean, and Codruta Soica, and Madalina Boruga, and Brigitha Vlaicu, and Mirela Danina Muntean
January 1990, Cancer chemotherapy and pharmacology,
Dorina Coricovac, and Cristina Adriana Dehelean, and Iulia Pinzaru, and Alexandra Mioc, and Oana-Maria Aburel, and Ioana Macasoi, and George Andrei Draghici, and Crina Petean, and Codruta Soica, and Madalina Boruga, and Brigitha Vlaicu, and Mirela Danina Muntean
March 2000, Neurochemistry international,
Dorina Coricovac, and Cristina Adriana Dehelean, and Iulia Pinzaru, and Alexandra Mioc, and Oana-Maria Aburel, and Ioana Macasoi, and George Andrei Draghici, and Crina Petean, and Codruta Soica, and Madalina Boruga, and Brigitha Vlaicu, and Mirela Danina Muntean
April 1999, Bioorganic & medicinal chemistry letters,
Copied contents to your clipboard!